KIT and small cell lung carcinoma: In the present study, we employed an additional antibody 67A2 that has a higher affinity for c-kit compared with 12A8, and evaluated the therapeutic efficacy of 90Y-labeled 12A8 and 67A2 in an SCLC mouse model.